← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Siga Technologies, Inc.
Corvallis, OR
$62,824,659
Total funding
20
Grants
Funding over time
peak $27.8M · FY2005–15$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$62,824,659 · 19
CDC$0 · 1
By mechanism
R44$25,394,116 · 4
N01$21,055,527 · 2
R01$10,873,514 · 2
R43$3,555,929 · 9
U01$1,667,535 · 1
R41$252,038 · 1
Investigators at Siga Technologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Development of a Smallpox Antiviral$11,484,928
N01 · FY2008 · AI
Advanced Development of Smallpox Therapeutics$9,570,599
N01 · FY2008 · AI
Antiviral Drugs for Lassa Fever Virus$3,901,282
R44 · FY2008 · AI
Antiviral Drugs for Category A Arenavirus$3,214,689
R44 · FY2005 · AI
Small Molecule Inhibitors of Smallpox Virus Replication$2,912,626
R44 · FY2005 · AI
Small Molecule Inhibitors of Smallpox Virus Replication$2,177,971
R44 · FY2004 · AI
Antiviral Drugs for Category A Arenavirus$2,092,539
R44 · FY2004 · AI
Small Molecule Inhibitors of Smallpox Virus Replication$1,829,082
R44 · FY2008 · AI
Antiviral Drugs for Arenaviruses$1,779,213
R01 · FY2011 · AI
Small Molecule Inhibitors of Smallpox Virus Replication$1,751,533
R44 · FY2007 · AI
Small Molecule Inhibitors of Smallpox Virus Replication$1,513,613
R44 · FY2006 · AI
Antiviral therapeutics for flavivirus infections$1,442,798
R01 · FY2011 · AI
Antiviral Drugs for Arenaviruses$1,435,943
R01 · FY2012 · AI
Antiviral Drugs for Arenaviruses$1,364,947
R01 · FY2013 · AI
Antiviral therapeutics for flavivirus infections$1,260,044
R01 · FY2012 · AI
Antiviral therapeutics for flavivirus infections$1,246,033
R01 · FY2014 · AI
Antiviral therapeutics for flavivirus infections$1,192,443
R01 · FY2015 · AI
Broad-spectrum, small-molecule inhibitors of bunyaviruses$1,174,957
U01 · FY2009 · AI
Antiviral Drugs for Lassa Fever Virus$1,160,831
R44 · FY2007 · AI
Antiviral therapeutics for flavivirus infections$1,152,093
R01 · FY2013 · AI